CLINICAL_TRIALS
trial_result
· 2011-03-24
Clinical Trial Update: Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV) [Phase 2]
Summary
This document reports a Phase 2 dose-ranging study of APD405 for postoperative nausea and vomiting (PONV). Results were posted in March 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Acacia Pharma Ltd | Conditions: Postoperative Nausea and Vomiting | Phase 2 | Status: COMPLETED | Results posted: 2011-03-24